An atypical alpelisib-induced hyperglycemic hyperosmolar and diabetic ketoacidosis state: A case report and critical analysis of alpelisib-induced hyperglycemia management guidelines

Ann Endocrinol (Paris). 2022 Aug;83(4):264-267. doi: 10.1016/j.ando.2022.02.004. Epub 2022 Apr 27.

Authors

Karima Chafai¹, Vanessa Balla¹, Hamida Oumbiche¹, Joël Ezenfis², Alfred Penfornis³, Coralie Amadou⁴

Affiliations

¹ Diabetes department, Sud-Francilien hospital, Corbeil-Essonne, France.
² Oncology department, Sud-Francilien hospital, Corbeil-Essonne, France.
³ Diabetes department, Sud-Francilien hospital, Corbeil-Essonne, France; Paris-Saclay university, Paris, France.
⁴ Diabetes department, Sud-Francilien hospital, Corbeil-Essonne, France; Paris-Saclay university, Paris, France. Electronic address: coralie.amadou@u-psud.fr.

PMID: 35750516
DOI: 10.1016/j.ando.2022.02.004

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Diabetes Mellitus*
Diabetic Ketoacidosis* / chemically induced
Diabetic Ketoacidosis* / drug therapy
Humans
Hyperglycemia* / chemically induced
Hyperglycemia* / drug therapy
Thiazoles

Substances

Thiazoles
Alpelisib